Introduction
Among the Alphaherpesvirinae there exists a number of well characterized proteins which are glycosylated and found in both the virus envelope and the cellular membrane [for a review of the herpes simplex virus type 1 (HSV-I) glycoproteins see Marsden (1987) ]. These glycoproteins (gB, gC, gD, gE, gI, gG and gH) all appear to have a similar structure in that they have a large N-terminal external domain which is glycosylated, a membrane-spanning domain towards the C terminus and a short internal (or cytoplasmic) region. However, recent evidence has suggested that other forms of membrane proteins could be encoded by the genomes of herpesviruses, as the products of certain genes of HSV-1, human cytomegalovirus and Epstein-Barr virus contain multiple regions of amino acid sequence that could form membrane-spanning domains (MacLean et al., 1991; Lehner et al., 1989; Fennewald et al., 1984) .
Equine herpesvirus type 1 (EHV-1) may contain up to 12 envelope glycoproteins (Turtinen & Allen, 1982; Meredith et al., 1989) , of which one, glycoprotein 300 (gp300), is unusual in that it is modified by very high levels of O-linked carbohydrate, together with some N-linked glycosylation (Whittaker et al., 1990) . The gene encoding gp300 (or gp2) was originally mapped to the EcoRI I fragment of the EHV-1 genome between map units 0.279 and 0.344 (Allen & Yeargan, 1987) . This t Present address: Department of Oral Biology, Leeds Dental Institute, University of Leeds, Leeds LS2 9LU, U.K. fragment is homologous to the region of the HSV-1 genome between the UL30 and UL36 genes. The limits of the gene encoding gp300 have been more finely mapped to an EcoRI-PvulI fragment within the EcoRI I fragment, and DNA sequence analysis has shown that this region encodes part of a gene homologous to HSV-1 DNA polymerase and homologues of HSV-1 genes UL31 and UL32 . To establish whether EHV-1 gp300 is encoded by the UL32 homologue, a portion of this gene was cloned into a prokaryotic expression vector and the induced protein was shown to react with anti-gp300 monoclonal antibodies (MAbs). The modification of gp300 with lipid has also been studied, together with the effects of anti-gp300 MAbs on cell-cell fusion.
Methods
Construction of recombinant plasmids. Recombinant DNA manipulations were carried out using standard methods (Sambrook et al., 1989) . Plasmid DNA was digested with restriction enzymes and electroeluted fragments were ligated into vectors as described by the manufacturer (BRL). Plasmids were transformed into Escherichia colt (strain SURE) (Stratagene) as recommended by the manufacturer. DNA polymerase I (BRL) was used for filling the 5' termini of restriction-digested DNA.
Colony hybridization. Colonies from transformations were plated in duplicate onto a master agar plate and a Genescreen filter (DuPont) laid on top of a second agar plate, and incubated at 37 °C for 16 h. The master plates were stored at 4 °C, and the colonies growing on the filters were lysed and DNA was fixed essentially as described by Sambrook et aL (1989) . Filters were then pre-hybridized with 50% (v/v) formamide, 0001-1153 © 1992 SGM 16 h. DNA probe was added to the prehybridization solution and incubated at 42 °C for at least 16 h. The filter was washed with 2 x SSC at 60 °C for 1 h, 0.2 x SSC at 60 °C for 1 h, and finally with 25% (v/v) formamide, 0-2% SSC at 60 °C for 1 h. All buffers were as described by Sambrook et al. (1989) . Plasmid DNA was purified from positive colonies by use of a Miniprep Kit Plus (Pharmacia), and restriction analysis of recombinants was carried out under conditions recommended by the manufacturer (BRL).
Expression of the EHV-1 UL32 homologue. A culture of E. coli carrying the recombinant plasmid was grown to an optical density of 3.0 in 100 ml LB medium containing 50 ~g/ml ampicillin at 37 °C, and was then induced to produce fusion protein by the addition of IPTG to a final concentration of 0.1 mM. After 1 h, cells were centrifuged at 10000 g for 15 min and resuspended in 1 ml PBS, and approximately 10 ~tl of this was analysed by SDS PAGE and Western blotting.
SDS-PAGE, Western blotting and immune precipitation. Gels for
SDS-PAGE contained 12% acrylamide and were cross-linked with N,N'-diallyltartardiamide (DATD) (Heine et al., 1974) . For Western blotting, gels were transferred to nitrocellulose membranes as described previously (Towbin et al., 1979) ; blots were developed using a Vectastain ABC kit (Vector Laboratories) using chloronaphthol/ H202 for colour development. For immune precipitation, Protein A-Sepharose (10 ~tl of a 50% suspension) (Pharmacia) was pre-incubated with 10 pl of rabbit anti-mouse immunoglobulins (Dako-Patts) at room temperature, washed three times with PBS, then incubated with 10 ~1 of MAb ascitic fluid at room temperature for 1 h and washed three times with PBS. Soluble virus extract was prepared by incubation of purified EHV-1 with 0-5% (v/v) Triton X-100 for 30 min at 4 °C. This was then incubated with the antibody-Protein A complex at 4 °C overnight with shaking, followed by five washes with RIPA buffer (150 mM-NaC1, 0.5% w/v NP40, 0-1% w/v sodium deoxycholate, 0.1% w/v SDS, 50 mM-Tris-HC1 pH 7.0). Bound material was eluted with SDS-PAGE sample buffer at 100 °C for 5 rain prior to scintillation counting.
MAbs. MAbs P19, F3124 and 1G12 (specific for gp300), P50 and c~D3B4 (specific for EHV-1 gB), 92b (specific for EHV-1 gC) and P68 (specific for EHV-1 gD) have been described previously (Allen & Yeargan, 1987; Meredith et al., 1989; Stokes et al., 1991 ; Whittaker et al., 1990 .
Cell culture and radiolabelling of virus polypeptides. Rabbit kidney (RK13) cells were grown using the autoclavable form of Dulbecco's medium (Sigma) supplemented with 2 mM-glutamine, 0-t% (w/v) sodium bicarbonate, 0.12 mg/mt penicillin, 0-1 mg/ml streptomycin and 10 % (v/v) newborn calf serum. EHV-I (strain Ab-1) was used in all experiments described and cells were infected in medium containing 2% (w/v) calf serum.
To label virus structural proteins with amino acids, cells were infected with 0.1 p.f.u. EHV-1/cell and labelled from 8 to 30 h postinfection (p.i.) with 0.3 ktCi/ml each of L-[14C]leucine (330 mCi/mmol), L-[14C]isoleucine (240 mCi/mmol) and L-[14C]valine (275 mCi/mmol), using medium containing one-tenth the normal level of leucine, isoleucine and valine. To label virus structural proteins with lipids, ceils were infected with 0.1 p.f.u. EHV-1/celI, and labelled from 8 to 30 h p.i. with 5 ~tCi/ml [9,10(n)-3H]palmitic acid (40 to 60 Ci/mmol). Extracellular virus was then purified as described previously (Meredith et al., 1989) . To label infected cell polypeptides with lipids, cells were infected at a multiplicity of 5 p.f.u./cell with EHV-1, or were mock-infected. Cells were labelled at 8 h p.i. with 10 ktCi/ml [9,10(n)-3H]palmitic acid (40 to 60 Ci/mmol), and harvested at 16 h p.i. All radioisotopes were obtained from Amersham.
HPLC of fatty acids. Purified EHV-1, labelled with [3H]palmitate, was treated with PBS, 1% (v/v) Triton X-100 at 4 °C for lh, and soluble material was extracted by centrifugation at 10000 g for 15 min. The supernatant was treated with nine volumes of acetone and stored at -20 °C overnight. Precipitated material was recovered by centrifugation at 10000 g for 15 min, and the pellet was washed with acetone, air-dried and resuspended in PBS, 1% (v/v) Triton X-100. Non-proteinbound lipid was extracted with 100 volumes of water-saturated ether and released lipid was assayed by scintillation counting. Extractions were continued until no further radioactivity could be assayed in the ether fraction.
Protein-bound lipid was released by treating the glycoprotein extract with an equal volume of 2 M-hydroxylamine pH 7.0 for 4 h at room temperature (Olson et al., 1985) and released material was extracted with chloroform :methanol (2:1). The solution of released lipid was then dried down and resuspended in 200 pl HPLC grade methanol (BDH) containing 30 ~tg/ml myristic acid, 62.5 ktg/ml palmitic acid, 125 ~tg/ml myristic acid methyl ester and 125 lag/ml palmitic acid methyl ester (all obtained from Sigma). Lipid species were fractionated using an LKB GTi HPLC system. Samples were loaded on a Spherisorb $5ODS2 HPLC column (0.46 x 25 cm) (Anachem) and eluted with 80% (v/v) acetonitrile (BDH) at a flow rate of 1 ml/min. The eluate was monitored at 208 nm, to identify marker lipids, and fractions (2 ml) were collected, allowed to dry in air and assayed by scintillation counting.
Assay of cell cell fusion. RK cells were grown overnight in a 24-well
tissue culture vessel to achieve confluent monolayers. Cells were infected with EHV-1 at a multiplicity of 5 p.f.u./cell, and virus was allowed to adsorb for 1 h at 37 °C. Monolayers were washed with medium, which was replaced with medium containing various concentrations of purified MAb. Ceils were incubated at 37 °C for 18 h, fixed with 0.25% (v/v) glutaraldehyde and then washed with PBS before photomicrography. MAb 1G 12 (IgG) was purified by binding to a column of Protein A-Sepharose followed by elution with 0.2 Mglycine-HC1 pH 2-2. MAb F3124 (IgM) was purified by HPLC gel filtration. Both antibodies were dialysed against PBS before use and purity was confirmed by SDS-PAGE. Protein concentrations were determined using a commercial kit (Bio-Rad).
Results

Construction of fusion protein-expressing plasmids
The DNA sequence of the EHV-1 strain Ab-1 gene showing homology to HSV-1 gene UL32 was determined (W. A. Bonass, D. M. Elton & G. R. Whittaker, unpublished results) (GenBank accession number, M84239); it is equivalent to gene 28 present in the genome of EHV-1 strain Ab-4 (Telford et al., 1992) (GenBank accession number, M86664). The predicted amino acid sequence of the gene 28 product of Ab-4 is identical to that determined for Ab-1. The Ab-1 DNA sequence was utilized to design constructs for ligation into the prokaryotic expression vector pGEX-2T (Pharmacia), which produces a fusion protein in which the foreign protein is linked to the C terminus of glutathione S-transferase (GST) (Smith et al., 1986) . The EcoRI I fragment of EHV-1 strain Ab-1 DNA was cloned into the EcoRI site of pUC18 to give plasmid pBB809, and a BamHI-SalI fragment from this plasmid The EcoRI I fragment of EHV-1 DNA was cloned into pUC18 to give plasmid pBB809. A BamHI-SalI fragment of pBB809 was subcloned into pUC18 to give pBB225, and a ClaI-Xbal fragment of this was then cloned into pGEX-2T to give plasmids pBB403 and -404. (b) Diagram of plasmid pBB404, which encodes a fusion protein of GST linked to the product of the XbaI-ClaI fragment from the EHV-I UL32 gene homologue.
was subcloned into the BgllI and XhoI sites of p U C 18 to give pBB225. This plasmid contains the majority of EHV-1 gene 28, but lacks approximately 120 bp at the 3' end and 540 bp at the 5' end of the gene. To generate recombinant plasmids for expression, an XbaI-ClaI fragment from pBB225 was electroeluted from an agarose gel, and the 5' extensions were filled with D N A polymerase I and then ligated into the Sinai site of pGEX-2T. This fragment contains codons 107 to 504 of EHV-1 gene 28. This ligation mix was then used to transform E. eoli and colonies containing EHV-1 D N A were identified by colony hybridization using a 32p-end-labelled XbaI-ClaI fragment from pBB225 as a probe. Plasmid D N A was isolated from positive clones and the orientation of the insert was determined by digestion with PstI and SstlI as shown in Fig. 1 . Clones were termed pBB404 (correct orientation for expression from the tac promoter) and pBB403 (incorrect orientation) and are shown in Fig. 1 . The presence of EHV-1 gene 28 in the correct reading frame within pBB404 was confirmed by D N A sequencing using an end-labelled deoxyoligonucleotide primer (5' C G A C C A T C C T C C A A A A T 3'), derived from the C-terminal sequence of G S T (Smith et al., 1986 (Smith et al., , 1987 ) (data not shown).
Expression of the EHV-1 UL32 homologue in E. coli
Induction of cells containing p G E X -2 T or pBB403 resulted in the synthesis of a protein of approximately 30K, whereas with pBB404 a fusion protein of 70K was induced (Fig. 2a, lane 6) . The fusion protein produced from pBB403 is actually slightly smaller than that produced from pGEX-2T, because in pBB403 the presence of EHV-1 gene 28 in the incorrect orientation means that a termination codon is present immediately after the cloning site, whereas for p G E X -2 T the termination codon is present 15 bp downstream. The 70K fusion protein produced from pBB404, together with a weakly reacting band o f slightly lower Mr, reacted with the M A b P19 (Fig. 2b) , which is specific for EHV-1 gp300 (Whittaker et al., 1990) . The weakly reacting band is likely to be due to a small amount of proteolysis taking place during induction. A n u m b e r of other polypeptides are also reactive on the blot, but these are present in all lanes and are most likely to be due to non-specific binding of the antibody. Other MAbs specific for gp300 [including 1G12, which was used by Allen & Yeargan (1987) to map the gene encoding gp2] were tested, but failed to react with the fusion protein (data not shown). This is possibly due to the epitope recognized by 1G12 lying outside the portion of gp300 expressed. The 70K fusion protein produced from cells containing pBB404 corresponds to amino acids 107 to 504 of the EHV-1 gene 28 product linked to GST, and since this fusion protein is recognized by an anti-EHV-1 gp300 MAb, this confirms that the EHV-1 gene 28 encodes gp300, which has been shown to be a m e m b r a n e protein present in both the virus particle and in virus-infected cells.
The predicted amino acid sequence of EHV-1 strain Ab-1 gp300 is shown in Fig. 3 , and a hydrophobicity profile is shown in Fig. 4 . The latter indicates that the protein has five domains that may interact with or span the membrane. These regions are far from typical as classical membrane spans. In all cases there are charged or polar amino acids within each domain. There is a possibility that certain cysteine residues close to these regions are fatty acylated and may stabilize the structure either proximal to or within the lipid bilayer. We would stress that it is difficult, at the moment, to predict the orientation of this protein with regard to the lipid bilayer in which it seems to be inserted.
A cyla tion of EH I1"-1 -specific polypeptides
To investigate further the post-translational modification of gp300 and to gain further information on its m e m b r a n e association, infected cells were labelled with [3H]palmitic acid and EHV-1 was purified. This resulted in the low incorporation of radiolabel into three polypeptides, and these are shown in Fig. 5 . When EHV-l-infected cells were labelled with [3H]palmitic acid and analysed directly by SDS-PAGE and autoradiography, no proteins could be detected after prolonged exposure of the gel. In the case of gp300 this is likely to be because levels of this protein are very low within infected cells (G. Whittaker, unpublished data), and therefore are not detectable by this technique.
Immune precipitation of purified virus labelled with [3H]palmitic acid using MAb P19 confirmed that gp300 is palmitylated (Fig. 6a) . The presence of palmitic acid on EHV-1 gC and gD was also confirmed by the precipitation of radiolabel with MAbs 92b and P68, respectively. Palmitylation of EHV-1 gB could not be determined conclusively; although MAb ~D3B4 precipitated a small amount of radiolabel, P50 precipitated no radiolabel. The presence of protein in all of these immune precipitates was confirmed by immune precipitation of a duplicate preparation of purified EHV-1 labelled with [35S]methionine (Fig. 6b ). HPLC analysis of label released from [3H]palmitic acid-labelled purified EHV-1 by hydroxylamine treatment confirmed that palmitate was present, as the major peak of radioactivity was eluted in the same fraction as the palmitic acid marker (Fig. 7) .
Role of gp300 in cell-cell fusion
EHV-l-infected RK cells show pronounced syncytia, resulting in the formation of giant multinucleate ceils; this phenomenon was used as a convenient assay of cell fusion. Monolayers of RKI3 cells were grown, infected with EHV-1 and MAbs specific for gp300 added to tissue culture medium 1 h after infection. At 16 h p.i. cells were monitored by microscopy for effects of the antibodies on cell-cell fusion. A typical c.p.e, of RK cells infected with EHV-I is demonstrated in Fig. 8(b) , (i) and (ii). These panels show the effects of a MAb which has no demonstrable effects on cell fusion by this assay; both show giant, 'balloon-like', multinucleate ceils. Treatment of cells with MAb 1G12 produced a different pattern of c.p.e, due to the inhibition of fusion between EHV-1infected cells; this is shown in Fig. 8 (a) . Effects on cell fusion were most noticeable at concentrations of 75 ~tg/ml and greater, with complete absence of the characteristic multinucleate cells usually seen with EHV-l-infected RK cells (Fig. 8a, panel iii) . The c.p.e. at this concentration of 1G12 was characterized by individual cells that had rounded up. At a concentration of 50 ~tg/ml a decrease in the overall amount of cell fusion was apparent (Fig. 8 a, panel ii) , and below 25 I~g/ml a normal pattern of c.p.e, was seen ( Fig. 8a, panel i) . Other MAbs to gp300 (including P19) and other EHV-1 glycoproteins were tested but these showed no effect on cell--cell fusion. 
Discussion
The gene encoding gp2, a major envelope glycoprotein of EHV-1, was located to the EcoRI I fragment of the EHV-1 genome (Allen & Yeargan, 1987) , and by use of MAbs this glycoprotein has been shown to be identical to the glycoprotein gp300 (L. Taylor, personal communication). Expression of a portion of the EHV-1 homologue of HSV-1 UL32 resulted in the production of a fusion protein which reacted on Western blots with MAb P19, which is specific for EHV-1 gp300, confirming that the gp300 gene is a homologue of HSV-1 gene UL32.
EHV-1 gene 28 is homologous to HSV-1 gene UL32 and varicella-zoster virus (VZV) gene 26, and has been given FastA homology scores of 1499 with VZV gene 26 and 1393 with HSV-1 UL32 (Telford et al. 1992) , indicating that these genes are very highly conserved. Levels of amino acid identity are over 50% between the predicted amino acid sequences of these genes, and homology is also found with members of the Beta-and Gammaherpesvirinae (Baer et al., 1984; Chee et al., 1990) . As homologues of this gene are present in all subfamilies of the Herpesviridae, gp300 therefore represents the first member of a new family of herpesvirus glycoproteins to be identified as a structural component.
The EHV-1 EcoRI I fragment also contains a gene homologous to HSV-1 gene UL36, and analysis of a homologue of this gene in the closely related virus EHV-4 has resulted in the identification of the UL36 gene homologue as the gene encoding another high Mr protein termed gpl/2 in EHV-4 (W. A. Bonass, unpublished data). However, the data presented in this paper show that the glycoprotein termed gp300 (or gp2) in EHV-1 is encoded by a gene 28, which is homologous to HSV-1 gene UL32.
Analysis of the hydrophobicity of the HSV-1 UL32 gene product showed that the polypeptide may have an N-terminal signal sequence and between three and five hydrophobic domains. However, these are relatively weak and because of this the protein encoded by HSV-1 gene UL32 was not classified as a possible membrane protein by McGeoch et al. (1988) . Despite this, HSV-1 gene UL32 was thought to represent a good candidate as a homologue of the gp300 gene because the Mr of the predicted product of the EHV-1 UL32 gene (67K) is very similar to that of both the HSV-1 UL32 gene product (64K) and identical to that of the deglycosylated form of gp300 (67K) (Whittaker et al., 1990) .
EHV-1 gp300 does not contain a region with homology to sequences containing known signal cleavage sites (von Heijne, 1988) . This would indicate that gp300 is a member of the group of proteins that are inserted into the membrane in the absence of a cleavable signal sequence, i.e. a member of the type IIIb membrane protein group (Singer, 1990) . Little is known about the insertion of these proteins (such as rhodopsin and cytochrome P-450) into the membrane, but it is thought that similar mechanisms to the insertion of cleavable signal sequence-containing proteins are used, i.e. are dependent on the binding of a signal recognition particle (Sakaguchi et al., 1984; Wessels & Speiss, 1988) .
Modification of membrane proteins with palmitic acid is most likely to occur as a thioester bond linked to cysteine residues (Sefton & Buss, 1987) , and often occurs in areas containing multiple hydrophobic residues (Okubo et al., 1991 ; Veit et al., 1991) . For many proteins, this is thought to act as an additional site of membrane association (Mcllhenny, 1990) . Gp300 contains 24 cysteine residues, and those at positions 46, 100, 103,433 and 436 show features which indicate that they may be the site of palmitate addition, i.e. they occur in highly hydrophobic regions. It is also thought that isoprenyl groups (another form of fatty acylation) act to anchor proteins to membranes (Glomset et al., 1990) . Isoprenyl groups are linked to proteins via cysteine residues which are part of a CAAX motif on the C terminus of proteins (Glomset et al., 1990) . For gp300, Cys 617 may also act as a site of fatty acid linkage. However, the two residues which follow Cys 617 are not good candidates for those expected in the following two positions (which according to the CAAX consensus motif are normally both aliphatic residues). No evidence has been obtained for isoprenylation of gp300 by labelling cells with [I4C]mevalonic acid, a precursor molecule for isoprenyl groups (data not shown). If the C terminus of gp300 is also isoprenylated, this is likely to act as a fifth site of membrane association. However, it it not certain whether hydrophobic domains 1 to 4 actually span the membrane or are simply associated with it on one face.
Certain features regarding the topology of gp300 can be determined because the protein is highly glycosylated, often by relatively short carbohydrate chains (Whittaker et al., 1990) , indicating that many sites of glycosylation are utilized. Therefore a major portion of gp300 is likely to be present as an external loop, and as MAb P19 has been shown by immune fluorescence to react on the external face of the cell (L. Taylor, personal communication), the epitope with which this antibody reacts must also be present on an external loop. MAb 1G12 appears to react with an epitope distinct from that recognized by P19 and inhibits EHV-l-induced fusion between infected RK cells. The surface location of the UL32 gene product is supported by the fact that the gene has been implicated as a locus of resistance to immune cytolysis; one of several temperature-sensitive mutations that render cells resistant to complement-dependent lysis maps to this region of the genome (Machtiger et al., 1980; Pancake et al., 1983) . This implies that at least a portion of the gene product is on the external surface of membranes and therefore is exposed to the immune system.
However, the fact that gp300 is palmitylated and has a role in cell--cell fusion processes may suggest a relationship. Although MAb 1G12 affects cell-cell fusion processes, it showed no effect on virus penetration (which also takes place via processes of membrane fusion), whereas MAbs specific for EHV-1 gD that block virus penetration show no effect on cell-cell fusion processes. This would indicate that the two fusion processes take place by independent means.
The gene encoding EHV-1 gp300 is presently being cloned into a variety of expression vectors to enable a more detailed study of the structure and function of this protein.
